CME Corner

This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

Program Detail

Release Date: November-16-11
Credit Expiration Date: November-16-12


Ray Dorsey, MD
Associate Professor of Neurology
Director, Johns Hopkins Movement Disorders Center
Johns Hopkins University
Baltimore, MD

Caroline M Tanner, MD, PhD, FAAN
Director, Clinical Research
Parkinson's Institute
Sunnyvale, CA

Irene Litvan, MD
Tasch Endowed Professor in Parkinson Disease Research
Director of the Movement Disorders Program,
Department of Neurosciences
UC San Diego
La Jolla, CA

Credit Hours

1.0 AMA PRA Category 1 Credits


Video Roundtable

Program Description

An estimated 1 million U.S. adults have Parkinson’s disease (PD), a progressive neurodegenerative movement disorder that affects motor and cognitive function and significantly impairs quality of life. Clinical advances related to treatment of both motor and non-motor symptoms of Parkinson’s disease provide clinicians with the opportunity to improve outcomes in patients with PD. In order to provide optimal care for patients with PD, clinicians need up-to-date information on PD and its management. Patients also desire good communication with clinicians who can provide education and the latest information to them on PD and its treatment.

Neurologists, and other clinicians who care for patients with PD, have an opportunity to improve outcomes in patients with PD by updating practice patterns to provide optimal treatment for patients with Parkinson’s disease based on current evidence. The goal of this continuing medical education activity is to bring neurologists and other clinicians up to date on current and evolving best practices in the management of PD, ultimately improving clinical performance and outcomes for individuals with PD.


o Front Matter and Pre-Test: 5 minutes
o Video Roundtable: 45 minutes
o Post-Test: 5 minutes
o Evaluation: 5 minutes

Program Developer/Facilitator

This activity is jointly provided by Global Education Group and MCM Education

Target Audience

The educational design of this activity addresses the needs of neurologists, neurological nurses, and other health care providers involved or interested in the treatment of patients with Parkinson's disease.

In order to obtain credit, participants must complete the activity in full as well as the Post-test and Evaluation.

Learning Objectives

Upon completion of this educational activity, the participant should be able to, based on recent data presented at ANA 2011:

  1. Explain the use of new diagnostic approaches and tools to facilitate accurate diagnosis of Parkinson's disease.
  2. Outline emerging new approaches presented at ANA 2011 that may improve motor symptoms in patients with Parkinson's disease.
  3. Describe new evidence-based treatment approaches presented at ANA 2011 to manage non-motor symptoms in patients with Parkinson's disease.
  4. Review emerging data and ongoing clinical research presented at ANA 2011 that focuses on improving outcomes in patients with Parkinson's disease.


Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Dr. Dorsey: Consultant and Research support: Lundbeck.

Dr. Tanner: Consultant: Impax Pharmaceuticals; Research support: Michael J. Fox Foundation, Brin Foundation, James and Sharron Clark Parkinson’s Institute and Clinical Center, Parkinson’s Disease Foundation, USAMRAA (TATRC managed NETRP Program), National Institute of Neurological Disorders and Stroke (NINDS), Agency for Healthcare and Research Quality
(AHRQ), Parkinson’s Unity Walk.

Dr. Litvan: Research support from: National Institutes of Health (NIA), CurePSP, Noscira, Allon Therapeutics, Parkinson Study Group, Parkinson Support Center of KY, National Parkinson Foundation.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Jackie Dawson, MSN: Nothing to disclose
Amanda Glazar, PhD: Nothing to disclose
Sara Thier, PHD, MPH: Nothing to disclose
Elizabeth Paczolt, MD: Nothing to disclose
David Heckard: Nothing to disclose

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Medical Communications Media, Inc. do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Credit Statements

Physician Continuing Medical Education

Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Global Education Group (Global) and Medical Communications Media, Inc. Global is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information about the accreditation of this program, please contact Global at 303-395-1782 or

Commercial Support Statements



Minimum Hardware/Software Requirements: Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7. Or, Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers • High-speed internet connection • Internet Explorer 6.x or higher, Firefox 2.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser • Adobe Flash Player and/or an HTML5 capable browser may be required for video or audio playback • Adobe Acrobat Reader

  1. Please turn off all pop-up blockers to assure access to the educational activity.
  2. Click on the "Start program" icon at the bottom of this page.
  3. The activity will take approximately 30 minutes to complete.
  4. After the activity has finished, click on the "Post-test" button.
  5. Instructions for completing and submitting the post-test and evaluation are provided on the post-test screen.

Certificate Fee



©2011, Medical Communications Media, Inc. All rights reserved. This activity is designed to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this video roundtable are those of the speakers and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, Global Education Group, or xxx. Any medications or other diagnostic or treatment procedures presented by the program faculty should not be utilized by clinicians without evaluation of their patients’ conditions and possible contraindications or risks or without a review of any applicable manufacturer’s product information and comparison with the recommendations of other authorities.

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu